NP and NS1 proteins of H5N1 virus significantly upregulated IFITM1, IFITM2, and IFITM3 in A549 cells.


Journal

African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451

Informations de publication

Date de publication:
Mar 2019
Historique:
entrez: 1 6 2019
pubmed: 1 6 2019
medline: 19 11 2019
Statut: ppublish

Résumé

Avian influence virus H5N1 causes serious public health concern with significant morbidity and mortality from poultry to humans. Interferon-induced transmembrane (IFITM) proteins usually protect cells from many virus infections by viral entry and replication. The purpose of this study was to investigate whether H5N1 viral proteins involved in regulation IFITM1, IFITM2, and IFITM3 following H5N1 infection. NS1, M1, NP, PB2, HA and NA genes of H5N1 virus were generated by PCR and cloned into pcDNA3.1/myc-His (+) A vector for genes over-expression experiments. Gene expression levels was performed using Real-time PCR. Research displayed that NS1, M1, NP, and PB2 proteins of H5N1 virus increased IFITM1, IFITM2, and IFITM3 expression in A549 cells, only IFITM1 was upregulated by M1 in HEK293T cells. However, our study did not find that HA and NA of H5N1 virus affected IFITM genes family or interferon genes expression. Taken together, our data suggested that IFITM1, IFITM2, and IFITM3 might be directly upregulated via NS1, M1, NP, and PB2 proteins during H5N1 avian influenza virus infection. This study provided new insights into the influence of NS1 and NP proteins on regulation of IFITM1, IFITM2, and IFITM3 expression following H5N1 infection.

Sections du résumé

BACKGROUND BACKGROUND
Avian influence virus H5N1 causes serious public health concern with significant morbidity and mortality from poultry to humans. Interferon-induced transmembrane (IFITM) proteins usually protect cells from many virus infections by viral entry and replication.
OBJECTIVES OBJECTIVE
The purpose of this study was to investigate whether H5N1 viral proteins involved in regulation IFITM1, IFITM2, and IFITM3 following H5N1 infection.
METHODS METHODS
NS1, M1, NP, PB2, HA and NA genes of H5N1 virus were generated by PCR and cloned into pcDNA3.1/myc-His (+) A vector for genes over-expression experiments. Gene expression levels was performed using Real-time PCR.
RESULTS RESULTS
Research displayed that NS1, M1, NP, and PB2 proteins of H5N1 virus increased IFITM1, IFITM2, and IFITM3 expression in A549 cells, only IFITM1 was upregulated by M1 in HEK293T cells. However, our study did not find that HA and NA of H5N1 virus affected IFITM genes family or interferon genes expression.
CONCLUSION CONCLUSIONS
Taken together, our data suggested that IFITM1, IFITM2, and IFITM3 might be directly upregulated via NS1, M1, NP, and PB2 proteins during H5N1 avian influenza virus infection. This study provided new insights into the influence of NS1 and NP proteins on regulation of IFITM1, IFITM2, and IFITM3 expression following H5N1 infection.

Identifiants

pubmed: 31148967
doi: 10.4314/ahs.v19i1.13
pii: jAFHS.v19.i1.pg1402
pmc: PMC6531959
doi:

Substances chimiques

Antigens, Differentiation 0
Carrier Proteins 0
IFITM2 protein, human 0
IFITM3 protein, human 0
INS1 protein, influenza virus 0
Membrane Proteins 0
NP protein, Influenza A virus 0
Nucleocapsid Proteins 0
RNA-Binding Proteins 0
Viral Core Proteins 0
Viral Nonstructural Proteins 0
Viral Proteins 0
leu-13 antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1402-1410

Références

Am J Pathol. 2001 Jan;158(1):119-30
pubmed: 11141485
J Leukoc Biol. 2004 Feb;75(2):163-89
pubmed: 14525967
J Virol. 2004 Sep;78(17):9499-511
pubmed: 15308742
Nature. 2004 Oct 7;431(7009):703-7
pubmed: 15470432
J Virol. 2005 Mar;79(5):2814-22
pubmed: 15709000
Adv Virus Res. 2005;64:383-416
pubmed: 16139601
Science. 2006 Nov 10;314(5801):997-1001
pubmed: 17038589
Virology. 2007 Jun 20;363(1):236-43
pubmed: 17320139
J Virol. 2007 Jul;81(13):7011-21
pubmed: 17442719
J Gen Virol. 2008 Oct;89(Pt 10):2359-76
pubmed: 18796704
Cell Host Microbe. 2009 May 8;5(5):439-49
pubmed: 19454348
J Virol. 2009 Oct;83(20):10557-70
pubmed: 19706713
EMBO J. 2010 Nov 17;29(22):3879-90
pubmed: 20924359
Virology. 2011 Mar 15;411(2):229-36
pubmed: 21237476
RNA Biol. 2011 Mar-Apr;8(2):207-15
pubmed: 21358279
J Virol. 2011 Jul;85(13):6618-28
pubmed: 21507966
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74
pubmed: 22371588
Nature. 2012 Mar 25;484(7395):519-23
pubmed: 22446628
Nat Rev Immunol. 2013 Jan;13(1):46-57
pubmed: 23237964
J Virol. 2013 May;87(9):5239-54
pubmed: 23449804
J Virol. 2013 Jul;87(14):7837-52
pubmed: 23658454
Annu Rev Virol. 2014 Nov 1;1:261-283
pubmed: 25599080
J Virol. 2015 Oct 14;90(1):103-16
pubmed: 26468537
Protein Pept Lett. 2016;23(4):372-8
pubmed: 26845765
J Immunol. 2016 Aug 1;197(3):824-33
pubmed: 27354218
Annu Rev Immunol. 1997;15:749-95
pubmed: 9143706

Auteurs

Haifeng Wang (H)

School of Environmental Engineering, Central Plains Specialty Food Engineering&Technology Research Center, Kaifeng Key Laboratory of Food Composition and Quality Assessment, Yellow River Conservancy Technical Institute, Dong Jing Avenue, Kaifeng 475004, China.
National Research Center for Wildlife-Borne Diseases, Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Chaoyang District, 100101, Beijing, China.

Lin Chen (L)

National Research Center for Wildlife-Borne Diseases, Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Chaoyang District, 100101, Beijing, China.

Jing Luo (J)

National Research Center for Wildlife-Borne Diseases, Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Chaoyang District, 100101, Beijing, China.

Hongxuan He (H)

National Research Center for Wildlife-Borne Diseases, Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Chaoyang District, 100101, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH